argenx SE | Results Presentation Deck | 24 slides

argenx · 2021-05
arc beats above · slides in the middle · loops below · scroll → 1 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

2
coverage by narrative range · generated from this deck JSON

Slide inventory

24
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
The slide uses a tree metaphor background to represent growth and foundation.summarize
04
The slide uses a series of circular metrics to present clinical trial outcomes.summarize
05
The chart shows a positive correlation between IgG reduction and MG-ADL improvement. The right side details the clinical trial design for the SC formulation.present_solution
Open slide detailBeat · Solution
06
Features patient testimonials/photos to humanize the clinical data.summarize
Open slide detailBeat · Solution
07
The slide uses a process flow diagram to illustrate the clinical trial phases.present_framework
Open slide detailBeat · Solution
08
The slide uses a process flow diagram to show the parallel structure of two clinical trials.present_framework
Open slide detailBeat · Solution
09
The slide uses a process flow diagram to illustrate the clinical trial stages.present_framework
Open slide detailBeat · Solution
10
The slide uses a process-flow diagram to map disease indications to franchises and proof-of-concept status.present_solution
Open slide detailBeat · Solution
11
present_solution
12
The slide uses a biological pathway diagram to illustrate the mechanism of action.present_solution
13
The slide uses a four-column layout to structure the disease profile.diagnose_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
14
The slide compares clinical outcomes (CR/CRc rates) for different patient cohorts and mentions a future decision point based on the ELEVATE trial.analyze_data
Open slide detailLoop · Cost Of Inaction
15
The diagram uses a hub-and-spoke model to visualize the flow of innovation from discovery to patient impact.present_framework
Open slide detailLoop · Cost Of Inaction
16
The slide uses a visual representation of an antibody molecule to map specific proprietary technologies (NHANCE, POTELLIGENT, DHS, ACT-Ig, ABDEG) to the Fc regipresent_solution
Open slide detailLoop · Cost Of Inaction
17
summarize
Open slide detailLoop · Cost Of Inaction
18
Standard quarterly financial reporting table showing revenue, expenses, operating loss, and EPS.analyze_data
Open slide detailLoop · Cost Of Inaction
19
The slide uses a circular, interconnected diagram to represent the launch strategy.plan_implementation
Open slide detailLoop · Cost Of Inaction
20
The slide uses a three-column layout to present different community engagement platforms.establish_context
Open slide detailLoop · Cost Of Inaction
21
establish_context
Open slide detailLoop · Cost Of Inaction
22
The slide uses a funnel-like visual to represent growth in indications, with color-coded dots representing therapeutic areas (Neuro, Heme, Skin, Kidney).plan_implementation
Open slide detailLoop · Cost Of Inaction
23
The slide uses a hub-and-spoke diagram to present strategic priorities.summarize
24
front_matter